Endologix LLC announced the appointment of Mike Mathias as the company?s Chief Commercial Officer, effective immediately. With a distinguished 30-year career in leading commercial organizations within the cardiovascular arena, Mike brings a wealth of experience and a proven track record of success to Endologix. With over three decades of leadership in commercial organizations within the medical device industry, Mike has contributed to the advancement of Endovascular Aneurysm Repair (EVAR) and therapies for Peripheral Vascular Disease.

His tenure included pivotal roles, notably leading the U.S. launch of the LimFlow System. Prior to joining LimFlow, Inc, he spent 20 years in various commercial leadership roles at Medtronic. He led Medtronic?s $1.2 billion Heart Valve Therapies U.S commercial operations, launching Transcatheter Aortic Valve Replacement (TAVR).

Mike's successful tenure at both Medtronic and LimFlow is distinguished by the launch of groundbreaking therapies, demonstrating his exceptional strategic planning, team leadership, and capability for market expansion. He earned his B.S. in Arabic and French Studies from the U.S. Military Academy at West Point, further enriching his leadership skills with an MBA from the University of Minnesota.